NIH-funded study identifies gene variant as potential drug target
Defying the odds, an individual at high risk for early-onset Alzheimer’s disease remained dementia-free for many years beyond what was anticipated. A study funded in part by the National Institute on Aging (NIA), part of the National Institutes of Health, led researchers to suggest that a gene variant may be the key, perhaps providing a new direction toward developing a treatment.
The research focused on the case of a woman who carried a gene mutation known to cause early-onset Alzheimer’s. However, she did not develop signs of the disease until her seventies, nearly three decades after her expected age of onset. The researchers suspect that she may have been protected because in addition to the gene mutation causing early-onset Alzheimer’s in her family, she also had two copies of the APOE3 Christchurch (APOE3ch) gene variant. Findings of this case study as published in Nature Medicine suggest that two copies of the APOE3ch variant, named after Christchurch, New Zealand where it was first identified, may protect against Alzheimer’s.
“Sometimes close analysis of a single case can lead to discovery that could have broad implications for the field,” said NIA Director Richard J. Hodes, M.D. “We are encouraged that as part of our wide array of studies, this research in the unique genetic makeup of an exceptional individual can reveal helpful information.”
Early-onset Alzheimer’s disease is rare, representing less than 10% of all people who have Alzheimer’s. It typically occurs between a person’s 30s to mid-60s. Risk for both early- and late-onset Alzheimer’s disease is affected by genetic factors.
For the study, researchers led by investigators at Massachusetts General Hospital, Boston, in collaboration with the University of Antioquia, Medellin, Colombia, Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, and Banner Alzheimer’s Institute, Phoenix, looked at genetic data from a Colombian family with more than 6,000 living members. Family members who carry a rare gene mutation called Presenilin 1 (PSEN1) E280A, have a 99.9% risk of developing early-onset Alzheimer’s disease.
The researchers confirmed that the woman in this case carried the PSEN1 E280A mutation, which caused early-onset Alzheimer’s in her other family members. However, she also had two copies of the APOE3ch gene variant, while no other affected family member carried two copies of this variant. Affected family members develop Alzheimer’s in their 40s, but she remained disease free until her 70s. Imaging tests showed that the woman had only minor neurodegeneration. She did have large amounts of amyloid protein deposits, a hallmark of Alzheimer’s disease, in her brain. But the amount of tau tangles, another hallmark of the disease, and the one more correlated with how thinking and memory are affected, was relatively low.
Experiments as part of the study showed that the APOE3ch variant may reduce the ability of APOE to bind to certain sugars called heparan sulphate proteoglycans (HSPG). APOE binding to HSPG has been implicated as one mechanism that may contribute to the amyloid and tau protein deposits that destroy the brain. The research suggests that a drug or gene therapy that could reduce APOE and HSPG binding has the potential to be a new way to treat or prevent Alzheimer’s disease.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- COVID-19 vaccination urged for people with Alzheimer’s, family caregiverson January 21, 2021 at 9:37 am
Getting vaccinated is one of the most important steps families affected by Alzheimer’s disease can take to protect themselves and their loved ones,” said J. Wesson Ashford, MD, PhD, Chair of AFA’s ...
- Alzheimer's deaths skyrocket as patients' lives 'upended' by pandemicon January 21, 2021 at 9:02 am
George Pitchford knew his wife, Bettie, a retired educator whose lively mind was lost in the fog that is Alzheimer's, was going to get worse. But he hadn't expected her to die, at least not so soon.
- Spike in Alzheimer’s deaths leads to calls on Oklahoma governor for pandemic reliefon January 21, 2021 at 7:58 am
The sharp rise in Alzheimer’s deaths in Oklahoma and around the U.S. is leading to calls on government leaders to help get through the coronavirus pandemic easier.
- Study potentially links low blood amylin level to reduced progression of Alzheimer's diseaseon January 21, 2021 at 6:26 am
More than 5.7 million Americans live with Alzheimer's disease and that number is projected to triple by 2050. Despite that growing number, there is not yet a cure.
- New studies support blood test for early detection of Alzheimer's diseaseon January 21, 2021 at 3:44 am
Researchers provide convincing evidence that an in-house developed blood test for Alzheimer's disease can detect the disease early and track its course, which has major implications for a potential ...
- Eli Lilly Stock Is Surging on Hope for Alzheimer’s Drug. Analyst Says It Won’t Last.on January 20, 2021 at 12:35 pm
The company has said it will provide detailed data on the treatment on March 13. The stock is up some 19% over the past week.
- Blood Biomarker May Predict Alzheimer's Disease Progressionon January 20, 2021 at 12:14 pm
Changes in plasma levels of p-tau181 are associated with progressive cognitive decline and reduction in gray matter volume in patients with amyloid beta.
- Five Habits That Can Decrease Chances of Alzheimer's, Even For Those With Genetic Riskon January 19, 2021 at 10:23 pm
Those who have a parent, a sibling, or multiple family ties with Alzheimer's are more likely to develop the disease than those who do not have a first-degree relative with Alzheimer's. Fortunately, ...
- Summerville Alzheimer's support nonprofit celebrates 25 years of serviceon January 19, 2021 at 11:55 am
Peg Lahmeyer and other members of St. Luke’s Lutheran Church in Summerville started a ministry dedicated to supporting people with Alzheimer's disease and the caregivers who look after ...
- Visual arts: Painter responds to mother's battle with Alzheimer's disease with arton January 19, 2021 at 1:10 am
Susanne Dotson's show at Sarah Gormley Gallery in the Short North was inspired by her mother, who died Dec. 20.
via Bing News